In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ExonHit, Allergan develop eye care, neurology drugs

Executive Summary

ExonHit Therapeutics (alternative RNA splicing) will work with Allergan (eye care and specialty pharmaceuticals) on the development of drugs to treat neurodegenerative diseases, pain, and ophthalmic disorders.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies